Tue.Nov 26, 2024

article thumbnail

Collaborative Health Care: The Essential Role of Pharmacists in Multidisciplinary Teams

Pharmacy Times

Pharmacists play a vital role in multidisciplinary health care teams by enhancing medication safety, optimizing therapeutic outcomes, expanding medication access, reducing costs, and improving patient education.

132
132
article thumbnail

STAT+: Amgen drug leads to substantial weight loss in study, but questions remain about competitiveness

STAT

New data from a mid-stage study of an Amgen obesity drug showed that it helped participants lose a substantial amount of weight, but questions about how competitive it could be appear to be shaping the response to the news, with the company’s share price falling on the announcement.  Amgen said Tuesday that that its drug, MariTide , led to an average of roughly 20% weight loss over a year in the Phase 2 study in participants who had obesity or who were overweight without type 2 diabe

137
137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CMS finalizes 6-year kidney transplant model with concessions to hospital lobby after critiques

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) finalized a six-year mandatory model to increase access to kidney transplants, the agency announced Nov. 26. | CMS made some concessions to hospitals who strongly criticized the kidney transplant model proposed rule in May.

Hospitals 127
article thumbnail

STAT+: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger

STAT

Recursion Pharmaceuticals, one of the most advanced companies using artificial intelligence and machine learning tools to expedite drug development , laid off employees after closing a merger last week.

137
137
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Biden proposes Medicare, Medicaid cover anti-obesity drugs

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) is attempting to cover anti-obesity medications under Medicare Part D and Medicaid, the agency announced Nov. 26. | With time running out before leaving office, the Biden administration is proposing a rule to have Medicare and Medicaid cover anti-obesity medications and bolster guardrails for AI, among the changes.

127
127
article thumbnail

Opinion: The disappearance of empathetic touch in medicine

STAT

As a physician, I was taught to appreciate the clinical importance of human touch for our physical and mental health. As a human being, I worry about its loss. And as a dermatologist, I know what that loss may mean for the loneliest and most vulnerable among us.  Scientific studies prove that human touch — whether it be a quick hug, holding a baby, or a professional massage — is important to our mental and physical well-being.

More Trending

article thumbnail

STAT+: New report urges guidelines — and some restrictions — on stem cell-based embryo models

STAT

LONDON — Policymakers and scientific groups need to specify guidelines for the burgeoning field that uses stem cells to mimic aspects of embryonic development, including by establishing certain red lines on research, an influential U.K. bioethics group said Wednesday in a new report.  Specifically, the report from the Nuffield Council on Bioethics says that researchers should not use these stem cell-based embryo models to try to start a pregnancy in a person or animal, and should not

135
135
article thumbnail

Cambridge Health Alliance taps Abridge's AI medical scribe to support multilingual patients

Fierce Healthcare

Providers are rapidly adopting generative AI-based clinical documentation tools to aid clinicians and make digital paperwork more efficient. | Cambridge Health Alliance, the only public academic health system in Massachusetts, is deploying Abridge's AI-based medical note-taking tool across its 600 clinicians after a successful pilot.

article thumbnail

STAT+: Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases

STAT

Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based drugs to treat rare diseases in the muscle, nervous system, and lung.  In addition to the upfront payment, Sarepta will also make a $325 million investment in Arrowhead, pay out $50 million a year for the next five years, and promise $300 million in “near-term” milestone payments related to clinical trial enrollment.

127
127
article thumbnail

How Pharmacists Can Stay Updated on Advancements in Diabetes Care

Drug Topics

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, talks about the best ways pharmacists can stay updated on advancements in diabetes medications and treatments.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Government watchdog calls out HHS for not auditing health care’s privacy compliance since 2017

STAT

The Office for Civil Rights is not checking whether health care providers and other people who handle Americans’ sensitive data are complying with federal health privacy law, a new report from the U.S. Department of Health and Human Services Office of the Inspector General has found.  The Office of Civil Rights, or OCR is in charge of enforcing HIPAA, the law that protects patients’ data from cyberattackers and other unauthorized parties.

HIPAA 125
article thumbnail

Independent Pharmacist on Navigating the Dynamic Pharmacy Profession

Drug Topics

Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, discussed the state of independent pharmacy.

article thumbnail

STAT+: Roche immunotherapy fails in lung cancer study, raising questions about drug’s target

STAT

LONDON — An experimental cancer treatment from Roche failed to improve survival in a major lung cancer study, the company said Tuesday, a result that will further stoke doubts about the drug’s target. In a short statement, Roche said that a combination of the drug, called tiragolumab, with its existing medicine Tecentriq did not outperform Tecentriq alone on the study’s primary endpoint of overall survival.

125
125
article thumbnail

GLP-1 receptor agonists aid broader outcomes in kidney disease, major analysis finds

European Pharmaceutical Review

Glucagon-like peptide-1 (GLP-1) receptor agonists have shown to provide meaningful benefits in chronic kidney disease (CKD) and individuals with and without diabetes. This based on the largest, most comprehensive analysis of GLP-1 antagonists on kidney and cardiovascular outcomes. While GLP-1 receptor agonists have shown benefit for type 2 diabetes, obesity and cardiovascular disease, its impact as a treatment in chronic kidney disease is not as clear, the researchers explained.

97
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Why AI may not help decrease radiologists’ burnout

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. How FDA categories may keep AI from relieving clinician burnout In a counterintuitive result, using AI did not reduce radiologists’ burnout, a recent JAMA Network Open study of over 6,700 radiologists in China found.

FDA 123
article thumbnail

Patients with Gout More Likely to Experience Ischemic Colitis | ACR Convergence

Drug Topics

Researchers aimed to address the associations between gout and ischemic events, specifically ischemic colitis.

98
article thumbnail

Inside the telehealth-fueled GLP-1 alternative market

STAT

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These medications have made tens of billions of dollars for drugmakers and have made their way into the public consciousness in a remarkable way.  Almost three-quarters of adults in the U.S. are overweight or obese, and obesity can lead to a litany of health complications, including heart disease, joint pain, and cancer.

FDA 119
article thumbnail

Biden ramps up Medicare coverage of obesity drugs

pharmaphorum

Outgoing US President Joe Biden has proposed a dramatic expansion of Medicare coverage of obesity drugs, but will the plan see the light of day?

104
104
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Roche’s TIGIT troubles continue, a novel Alzheimer’s target misses the mark, and other biotech news

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Happy Tuesday! Adam Feuerstein, here, filling in for your regular Readout correspondents.

109
109
article thumbnail

4 vitamins for post-COVID fatigue

The Checkup by Singlecare

When you’re sick with a viral infection, you expect to feel poorly for a few days. COVID is no exception. Whether you’re hit with respiratory, GI, or flu-like symptoms such as muscle pain, headache, and fatigue, testing positive for COVID means being down for the count for a bit before returning to your daily routine. However, what if you don’t bounce back, even after you’re technically recovered?

article thumbnail

Study Shows Adult HPV Vaccination Is Less Cost-Effective Than Adolescent Vaccination

Pharmacy Times

Investigators also found that vaccination for those aged 27 to 45 produces a higher number needed to vaccinate.

Vaccines 111
article thumbnail

Mount Sinai opens doors to new $100M research site for AI development

Fierce Healthcare

Mount Sinai Health System has opened the doors of its new AI research center in Manhattan, the Hamilton and Amabel James Center for AI and Human Health. | Mount Sinai Health System announced on Tuesday that it opened its Hamilton and Amabel James Center for Artificial Intelligence and Human Health, which will be a research site for AI development.

85
article thumbnail

Medigene axes staff and refocuses its TCR pipeline

pharmaphorum

Medigene slashes staff and delays trials of its lead TCR therapy candidate as it refocuses its pipeline.

111
111
article thumbnail

Although Rare, Shingles in Children Can Occur

Pharmacy Times

Although shingles is more common in adults, children who have had chickenpox or the chickenpox vaccine can develop shingles.

Vaccines 131
article thumbnail

Fast-growing Adragos snaps up Swiss CDMO Baccinex, significantly expanding fill-finish firepower

Fierce Pharma

German CDMO Adragos Pharma has been on a growth tear this year, drafting plans to boost capacity in Japan, upgrading a facility in France, taking over another from Fresenius Kabi in Norway and more | German CDMO Adragos Pharma has been on a growth tear this year. Now, the manufacturing arriviste—which was founded in 2020—is expanding its production network again with the acquisition of Switzerland's Baccinex, which specializes in fill and finish services.

80
article thumbnail

Roche buys off-the-shelf CAR-T player Poseida for $1bn

pharmaphorum

Roche has upgraded its partnership with off-the-shelf CAR-T therapy specialist Poseida to a $1 billion-plus takeover bid.

98
article thumbnail

Gilead adds investigational HIV vaccine to its portfolio from Spanish biotech   

Pharmaceutical Technology

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

article thumbnail

Shorla gains FDA nod for first oral liquid version of Novartis' Gleevec

Fierce Pharma

In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “am | Shorla Oncology has scored an FDA approval for its strawberry-flavored drink version of Novartis' cancer drug Gleevec. Dubbed Imkeldi, it becomes the first oral liquid form of imatinib.

FDA 76
article thumbnail

Gentlemen, Start Your Engines: DEA’s Marijuana Rescheduling Hearing Begins Monday

The FDA Law Blog

By Larry K. Houck — Last May the Department of Justice (“DOJ”) and the Drug Enforcement Administration (“DEA”) issued a Notice of Proposed Rulemaking (“NPRM”) to transfer marijuana from schedule I of the Controlled Substances Act (“CSA”) to schedule III. Schedules of Controlled Substances: Rescheduling of Marijuana, 89 Fed. Reg. 44,597 (May 21, 2024).

article thumbnail

MSD adds rocket fuel to Winrevair's engine in PAH

pharmaphorum

ZENITH trial of MSD's Winrevair in PAH could add further momentum to an already impressive launch.

97
article thumbnail

Text Messages Could Help Increase COVID-19 Booster Vaccine Uptake

Drug Topics

Individuals who received tailored text message reminders about receiving a COVID-19 booster vaccine were more likely to get it.

article thumbnail

Childhood Air Pollution Exposure Associated With Higher Risk, Persistence of Peanut Allergy

Pharmacy Times

Exposure to pollutants PM2.5 and NO2 was found to increase the likelihood of developing a peanut allergy and of the allergy persisting.

73
article thumbnail

How the incoming administration could impact FTC’s approach to M&A scrutiny

PharmaVoice

Pharma companies looking to get a break from the FTC under a new administration may be out of luck.

97